by Robin Dvorak | Jun 26, 2024
Adaptimmune is a fully integrated cell therapy company working to redefine how cancer is treated. With its unique engineered T cell receptor (TCR) platform, Adaptimmune is developing personalized medicines designed to target and destroy difficult-to-treat solid tumor...
by Robin Dvorak | Jun 26, 2024
AmplifyBio is a drug development and commercialization partner for advanced therapies. Launched out of Battelle in 2021, they provide industry-leading preclinical toxicology, safety, and pharmacology testing in an agile environment with analytics capabilities that...
by Robin Dvorak | Jun 26, 2024
SynOx Therapeutics Limited is a Dublin and Oxford -based, late-stage clinical biopharmaceutical company developing emactuzumab, a best-in-class monoclonal antibody against CSF-1R, for the treatment of Tenosynovial Giant Cell Tumour (TGCT) and other CSF-1 related and...
